From 71% to 96% Pre-Claim Affirmation Under the Review Choice Demonstration
Texas home health agency (~500 active patients) · Texas
71% → 96%
Pre-Claim Affirmation Rate
90%+
Threshold Cleared
19 days
Faster Avg Payment
2 cycles
To Full Turnaround
How a documentation-defense workflow lifted a Texas agency's RCD pre-claim affirmation rate from 71% to 96% — clearing the 90% threshold, protecting cash flow, and unlocking a lighter review burden.
The Challenge
A Texas home health agency serving about 500 active patients was struggling under the Review Choice Demonstration (RCD). It had selected pre-claim review, but its full provisional affirmation rate sat at 71% — well short of the 90% threshold CMS uses to grant a reduced-review option. Nearly three in ten pre-claim requests came back non-affirmed, each one delaying payment and forcing a resubmission. The root cause was not clinical care; it was documentation. Pre-claim packets were assembled inconsistently. Face-to-face encounter notes sometimes failed to tie the encounter to the primary reason for home health. Homebound status was frequently documented with template language rather than patient-specific detail. And skilled-need justification was often implied rather than clearly written. Because Texas is one of the six RCD states and pre-claim decisions gate payment, every non-affirmation translated directly into stalled cash flow — and the agency was at real risk of losing its ability to stay on the lighter-touch review path.
Our Solution
We rebuilt the agency's pre-claim process around a single principle: no packet goes out until it can defend itself. Every pre-claim request ran through a standardized documentation-defense checklist covering the three elements Medicare examines most closely — a compliant, encounter-linked face-to-face; individualized homebound documentation written to the specific patient; and explicit, skilled-need justification. Where the record fell short, a physician-query step closed the gap before submission instead of after a non-affirmation. We added deadline tracking so no pre-claim request slipped, and a feedback loop that pushed recurring weaknesses back into intake and clinical documentation, so the same gaps stopped recurring in new charts. Within two review cycles the affirmation rate cleared 90% and kept climbing — turning pre-claim review from a payment bottleneck into a predictable, front-loaded step.